Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
6.47
+0.27 (4.35%)
At close: Aug 13, 2025, 4:00 PM
6.47
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:35 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $562.86 million as of August 13, 2025. Its market cap has increased by 199.71% in one year.
Market Cap
562.86M
Enterprise Value
476.23M
1-Year Change
199.71%
Ranking
Category
Stock Price
$6.47
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $562.86M, an increase of 237.04%. That is a compound annual growth rate of 29.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 530.20M | 86.76% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |